Home › Funds › Royce & Associates › ORIC
Royce & Associates position in ORIC
ORIC PHARMACEUTICALS INC · Health Care
Latest position (Q2 2026)979.66K sh
Reported value held$10.61M
Portfolio Weight0.09%
First reportedQ2 2025
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 234.77K | $2.38M | New |
| Q3 2025 | 1.46M | $17.50M | Add |
| Q4 2025 | 1.51M | $12.33M | Add |
| Q1 2026 | 1.21M | $15.30M | Reduce |
| Q2 2026 | 979.66K | $10.61M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ORIC
- BlackRock Inc 6.82M sh · $73.90M · Q2 2026
- Viking Global Investors 5.13M sh · $55.52M · Q2 2026
- Alkeon Capital Management 3.74M sh · $40.49M · Q2 2026
- Vanguard Group 4.54M sh · $37.15M · Q4 2025
- Fidelity Management & Research (FMR) 2.64M sh · $28.54M · Q2 2026
- Citadel Advisors 2.62M sh · $28.39M · Q2 2026
- Goldman Sachs Group 2.45M sh · $26.55M · Q2 2026
- Geode Capital Management 2.09M sh · $22.64M · Q2 2026
- Franklin Resources 1.80M sh · $19.47M · Q2 2026
- Morgan Stanley 1.79M sh · $19.43M · Q2 2026
- D. E. Shaw & Co 1.58M sh · $17.11M · Q2 2026
- Bank of America Corp 1.08M sh · $11.68M · Q2 2026